Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.53 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL9547189 | 0.98 | HDAC8 (0.52) | HDAC8APOBEC3AAPOBEC3GKDM4ESMN1; SMN2 | |
| SCHEMBL30307002 | 0.78 | — | — | |
| SCHEMBL486914 | 0.76 | — | — | |
| Fluoride Ion SCHEMBL1896837 | 0.74 | HDAC8 (0.48) | HDAC8APOBEC3AAPOBEC3GKDM4ESMN1; SMN2 | |
| SCHEMBL372970 | 0.72 | HDAC8 (0.46) | HDAC8APOBEC3AAPOBEC3GKDM4ESMN1; SMN2 | |
| Fluoride Ion SCHEMBL1898517 | 0.71 | HDAC8 (0.45) | HDAC8APOBEC3AAPOBEC3GKDM4ESMN1; SMN2 | |
| SCHEMBL1829114 | 0.71 | APOBEC3A (0.46) | HDAC8APOBEC3AAPOBEC3GKDM4ESMN1; SMN2 | |
| SCHEMBL3458293 | 0.71 | APOBEC3A (0.54) | HDAC8APOBEC3AAPOBEC3GKDM4ESMN1; SMN2 | |
| SCHEMBL372853 | 0.69 | HDAC8 (0.47) | HDAC8APOBEC3AAPOBEC3GKDM4ESMN1; SMN2 | |
| SCHEMBL1835131 | 0.68 | HDAC8 (0.42) | HDAC8APOBEC3AAPOBEC3GKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12466956-B2 | Electroconductive resin composition and molded article of same | DENKA COMPANY LIMITED (JP) | 2025-11-11 | — | — | US | disclosed |
| WO-2022009445-A9 | ANTISTATIC AGENT, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE | 三洋化成工業株式会社 | 2025-01-16 | — | — | WO | disclosed |
| EP-4159824-B1 | ANTISTATIC AGENT, ANTISTATIC RESIN COMPOSITION, AND MOLDED PRODUCT | SANYO CHEMICAL IND LTD (JP) | 2025-01-01 | — | — | EP | disclosed |
| CN-115768850-B | Antistatic agent, antistatic resin composition and molded article | 三洋化成工业株式会社 | 2024-07-09 | — | — | CN | disclosed |
| CN-115698220-B | Antistatic agent, antistatic resin composition and molded article | 三洋化成工业株式会社 | 2024-05-07 | — | — | CN | disclosed |
| EP-4137625-B1 | ANTISTATIC AGENT | SANYO CHEMICAL IND LTD (JP) | 2024-03-27 | — | — | EP | disclosed |
| US-20230323001-A1 | ANTISTATIC AGENT, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| WO-2023189133-A1 | CONDUCTIVE RESIN COMPOSITION | デンカ株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-4134397-B1 | ANTISTATIC AGENT FOR THERMOPLASTIC RESINS | SANYO CHEMICAL IND LTD (JP) | 2023-08-30 | — | — | EP | disclosed |
| CN-115397919-B | Antistatic agent for thermoplastic resin | 三洋化成工业株式会社 | 2023-08-22 | — | — | CN | disclosed |
| EP-2093191-A1 | ACTIVATED CARBON AND METHOD FOR PRODUCING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2009-08-26 | — | — | EP | disclosed |
| US-20090161295-A1 | ELECTROLYSIS SOLUTION AND ELECTROLYTIC CAPACITOR USING THE SAME | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-06-25 | — | — | US | disclosed |
| US-20090147443-A1 | ELECTROLYTIC SOLUTION AND ELECTROLYTIC CAPACITOR USING THE SAME | PANASONIC CORPORATION (JP) | 2009-06-11 | — | — | US | disclosed |
| US-20090103241-A1 | Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-04-23 | — | — | US | disclosed |
| EP-2034497-A1 | ELECTROLYTE SOLUTION FOR ALUMINUM ELECTROLYTIC CAPACITOR, AND ALUMINUM ELECTROLYTIC CAPACITOR USING THE SAME | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-11 | — | — | EP | disclosed |
| US-20080316679-A1 | Electrolytic Solution for Electrolytic Capacitor, and Electrolytic Capacitor Using the Same | PANASONIC CORPORATION (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080094777-A1 | Electric double layer capacitor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-04-24 | — | — | US | disclosed |
| EP-1905740-A1 | ELECTRIC DOUBLE LAYER CAPACITOR | Sumitomo Chemical Company, Limited (JP) | 2008-04-02 | — | — | EP | disclosed |
| EP-1876611-A1 | ELECTRIC DOUBLE LAYER CAPACITOR | Sumitomo Chemical Company, Limited (JP) | 2008-01-09 | — | — | EP | disclosed |
| EP-1808875-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR UTILIZING THE SAME | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2007-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090103241-A1 | Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 | CBR1, CYP24A1, CALU | HDAC8 2618/4885APOBEC3A 3809/4885APOBEC3G 4252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.